Skip to content
Coalition for Headache and Migraine Patients

“For the tens of millions of Americans who endure the pain and disabling effects of migraine disease, we congratulate Amgen and Novartis on the FDA approval of erenumab. This new class of medicine is the first to be developed and approved for the prevention of migraine attacks. We now call on all stakeholders in healthcare…

Read More
Scroll To Top